Zobrazeno 1 - 6
of 6
pro vyhledávání: '"ARI G. OLROYD"'
Autor:
Xiaomeng Hu, Kathy White, Ari G. Olroyd, Rowena DeJesus, Antonia A. Dominguez, William E. Dowdle, Annabelle M. Friera, Chi Young, Frank Wells, Elaine Y. Chu, Cade Ellis Ito, Harini Krishnapura, Surbhi Jain, Ramya Ankala, Trevor J. McGill, August Lin, Kyla Egenberger, Allison Gagnon, J. Michael Rukstalis, Nathaniel J. Hogrebe, Corie Gattis, Ron Basco, Jeffrey R. Millman, Paul Kievit, Mark M. Davis, Lewis L. Lanier, Andrew J. Connolly, Tobias Deuse, Sonja Schrepfer
Genetic engineering of allogeneic cell therapeutics that fully prevents rejection by a recipient’s immune system would abolish the requirement for immunosuppressive drugs or encapsulation and support large-scale manufacturing of off-the-shelf cell
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::736dc650159ca6f52d32a1fd001b395d
https://escholarship.org/uc/item/95k656c6
https://escholarship.org/uc/item/95k656c6
Autor:
Xiaomeng Hu, Corie Gattis, Ari G. Olroyd, Annabelle M. Friera, Kathy White, Chi Young, Ron Basco, Meghan Lamba, Frank Wells, Ramya Ankala, William E. Dowdle, August Lin, Kyla Egenberger, J. Michael Rukstalis, Jeffrey R. Millman, Andrew J. Connolly, Tobias Deuse, Sonja Schrepfer
Publikováno v:
Science Translational Medicine. 15
Transplantation of allogeneic pancreatic donor islets has successfully been performed in selected patients with difficult-to-control insulin-dependent diabetes and impaired awareness of hypoglycemia (IAH). However, the required systemic immunosuppres
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::87ef67bc3b7c312fb3bf0929fddd52ca
https://doi.org/10.1126/scitranslmed.adg5794
https://doi.org/10.1126/scitranslmed.adg5794
Autor:
XIAOMENG HU, CORIE GATTIS, CHI YOUNG, ARI G. OLROYD, ELAINE Y.L. CHU, KATHY WHITE, ANNABELLE FRIERA, SONJA SCHREPFER
Publikováno v:
Diabetes. 71
Treatment of type 1 diabetes mellitus (T1DM) via allogeneic donor transplant has limited success due to morbidities from immunosuppression (IS) and a gradual loss of engrafted pancreatic islet function. We set out to engineer human primary pancreatic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fd2a8809277cd5035cbefef382914a06
https://doi.org/10.2337/db22-302-or
https://doi.org/10.2337/db22-302-or
Autor:
Hu, Xiaomeng, White, Kathy, Olroyd, Ari G., DeJesus, Rowena, Dominguez, Antonia A., Dowdle, William E., Friera, Annabelle M., Young, Chi, Wells, Frank, Chu, Elaine Y., Ito, Cade Ellis, Krishnapura, Harini, Jain, Surbhi, Ankala, Ramya, McGill, Trevor J., Lin, August, Egenberger, Kyla, Gagnon, Allison, Michael Rukstalis, J., Hogrebe, Nathaniel J.
Publikováno v:
Nature Biotechnology; Mar2024, Vol. 42 Issue 3, p413-423, 11p
Autor:
Hu, Xiaomeng, Gattis, Corie, Olroyd, Ari G., Friera, Annabelle M., White, Kathy, Young, Chi, Basco, Ron, Lamba, Meghan, Wells, Frank, Ankala, Ramya, Dowdle, William E., Lin, August, Egenberger, Kyla, Rukstalis, J. Michael, Millman, Jeffrey R., Connolly, Andrew J., Deuse, Tobias, Schrepfer, Sonja
Publikováno v:
Science Translational Medicine; 4/12/2023, Vol. 15 Issue 691, p1-16, 16p